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The authors studied noncancer mortality among phenoxyacid herbicide and chlorophenol
production workers and sprayers included in an international study comprising 36 cohorts from 12
countries followed from 1939 to 1992. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin or higher
chlorinated dioxins (TCDD/HCD) was discerned from job records and company questionnaires
with validation by biologic and environmental measures. Standard mortality ratio analyses
suggested a moderate healthy worker effect for all circulatory diseases, especially ischemic heart
disease, among both those exposed and those not exposed to TCDD/HCD. In Poisson regression
analyses, exposure to TCDD/HCD was not associated with increased mortality from
cerebrovascular disease. However, an increased risk for circulatory disease, especially ischemic
heart disease (rate ratio [RRI 1.67, 95% confidence interval [Cl] 1.23-2.26) and possibly diabetes
(RR 2.25, 95% Cl 0.53-9.50), was present among TCDD/HCD-exposed workers. Risks tended to
be higher 10 to 19 years after first exposure and for those exposed for a duration of 10 to 19
years. Mortality from suicide was comparable to that for the general population for all workers
exposed to herbicides or chlorophenols and was associated with short latency and duration of
exposure. More refined investigations of the ischemic heart disease and TCDD/HCD exposure
association are warranted. - Environ Health Perspect 106(Suppl 2):645-653 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-2/645-653vena/abstract.html
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Introduction
Workers exposed to phenoxyacid herbi-
cides and chlorophenols known to be cont-
aminated with dioxins, including the
2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) congener, consistently have been
shown to be at increased risk for all cancers
combined and, although less consistently,
for specific neoplasms such as lung cancer,
soft-tissue sarcoma, and non-Hodgkin's
lymphoma (1). TCDD exposure also has
been associated with numerous acute and
chronic adverse health effects among
humans (1,2). There is a complex network
ofresponses to dioxin exposure in animals
and humans accompanied by modulation
ofnumerous biochemical responses in tar-
get tissues and organs (1). Biochemical and
toxic effects are mediated by the intracellu-
lar aryl hydrocarbon receptor (3,4). There
is evidence that TCDD potently induces
transcription ofa distinct network oftarget
genes encoding xenobiotic-metabolizing
genes (5,6), affects expression ofgrowth
modulating genes (7), interacts with thy-
roid hormones (8), and modulates protein
phosphorylation (9), glucose metabolism
and transport (10,11), and estrogen
responses (12).
The most informative epidemiologic
studies ofchronic effects ofTCDD expo-
sure were conducted among U.S. Air Force
personnel exposed to TCDD-contami-
nated pesticides (13-16), pesticide users
and chemical production workers, includ-
ing groups ofworkers involved in indus-
trial accidents (17-26), and populations of
contaminated communities in Missouri in
the United States and Seveso, Italy (27-30).
Possible long-term nonneoplastic conse-
quences ofTCDD exposure appear to be
altered male reproductive hormone levels,
lipid metabolism, and thyroid function,
chronic elevated levels ofthe hepatic enzyme
y-glutamyl transferase, persistent chloracne,
reproductive toxicity, increased risk ofdia-
betes, and immunologic, renal, respiratory,
and cardiovascular disorders (1,2).
Occupational cohorts known to have
high exposure to TCDD have had incon-
sistent but suggestive findings with regard
to cardiovascular mortality. A large U.S.
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cohort (18) did not show an excess of
heart disease (standard mortality ratio
[SMR] =0.96) when compared to the gen-
eral population. In an international study
(19), the SMR for all circulatory disease
was 0.90. However, the English compo-
nent ofthe study showed a slight increase
in circulatory disease (SMR= 1.17) (31).
The small German accident cohort studied
by Ott and Zober (24) also did not show
an excess of heart disease. However, for
another German cohort ofchemical work-
ers, Flesch-Janys et al. (21) recently
reported mortality for all cardiovascular
diseases and ischemic heart disease to be
positively related to estimated TCDD
exposure levels when exposed workers were
compared to other industrial workers.
More detailed and thorough analysis of
cardiovascular disease risk clearly is war-
ranted given the potential for increased risk
of diabetes and altered lipid metabolism
amongTCDD-exposed workers.
The international study ofworkers who
produced or sprayed phenoxyherbicides (6)
was recently updated and enlarged to
indude cohorts from the United States and
Germany and offered an opportunity to
evaluate the long-term consequences and
chronic outcomes ofTCDD exposure with
some statistical precision because ofthe
large sample size and longer latency periods.
Results for cancer mortality were recently
reported (20). An assessment ofnoncancer
outcomes is presented here, with particular
emphasis on cardiovascular disease mortality
in relation toTCDD exposure.
Methods
The International Agency for Research on
Cancer multicentric mortality study is an
international cohort study of26,976 work-
ers producing or spraying phenoxyacid her-
bicides and chlorophenols and employed in
36 cohorts from 12 countries (Table 1). In
eight countries, 4160 workers employed in
the same companies but not exposed to
phenoxyacid herbicides and chlorophenols
were also enrolled in the study. These
workers, together with 592 workers with
unknown exposure rates and 361 workers
Table 1. Description ofthe cohorts in the IARC international mortality study, 1939 to 1992.
Workers, no.
Minimally or Serum
Cohort no, Exposed to notexposed to Date of Lost to Deaths, TCDD
country, type Gender TCDD/HCD TCDD/HCD follow-up follow-up, % no. samples, no. Main herbicides produced, formulated, or sprayed
1 Australia, S M 1840 0 1951-1983 3.3 620 37 2,4-D; 2,4,5-T
2 Austria, P M, F 159 0 1971-1991 3.1 21 47 2,4-D; 2,4,5-T; MCPA; 2,4,5-TCP; 2,4-DCP
3 Canada, S M 1142 81 1950-1992 3.4 152 0 2,4-D;2,4,5-T
4 Denmark, P M, F 0 1920 1947-1992 5.0 397 0 2,4-DP; MCPA; MCPP
5 Denmark, P M, F 0 198 1951-1992 2.0 28 0 2,4-DP; MCPA
6 Finland, P M, F 62 0 1939-1991 9.7 19 0 2,3,4,6-TeCP
7 Italy, P M, F 205 0 1970-1991 1.5 22 0 2,4,5-TCP
8 Italy, P M, F 0 60 1967-1991 10.0 4 0 2,4-D; MCPA
9 Netherlands, P M, F 524 38 1955-1991 5.5 140 31 2,4,5-T; 2,4,5-TCP
10 Netherlands, P M, F 0 419 1965-1991 1.7 31 0 2,4-D; MCPA; MCPP
11 NewZealand, P M, F 782 0 1969-1990 14.8 70 0 2,4-D;2,4,5-T; MCPA; MCPB;2,4,5-TCP
12 NewZealand, S M, F 699 0 1973-1990 4.1 35 9 2,4-D; 2,4,5-T; MCPA
13 Sweden, P M, F 244 0 1965-1990 1.6 24 5 2,4-D; 2,4,5-T; MCPA; MCPP; 2,4,6-TCP
14 United Kingdom, P M 0 1565 1947-1990 10.1 392 0 MCPA
15 United Kingdom, P M 145 0 1960-1989 1.4 49 0 PCP
16 United Kingdom, P M 572 369 1975-1991 3.6 83 0 2,4-D; 2,4,5-T; MCPA; MCPP; 2,4-DB; 2,4-DP
17 United Kingdom, P M 0 345 1963-1991 2.0 29 0 MCPB; PBA
18 United Kingdom, P M 0 271 1969-1991 5.2 19 0 MCPA; MCPP; 2,4-DB; 2,4-DP
19 United Kingdom, P M 479a 1969-1991 5.4 64 0 2,4-D; MCPA; MCPP; 2,4-DP
20 United Kingdom, S M 0 1992 1947-1990 8.6 418 0 MCPA
21 Germany, P M, F 576 59 1956-1989 0.9 89 19 2,4-0; 2,4,5-T; MCPA; MCPP; 2,4-DP
22 Germany, P M, F 1307 42 1952-1989 0.5 358 190 2,4,5-T; 2,5-DCP; 2,4,5-TCP
23 Germany, P M, F 313 179 1965-1989 13.4 21 0 2,4-0; 2,4,5-T; MCPA; MCPP; 2,4-DP
24 Germany, P M, F 126 15 1951-1992 2.1 24 20 2,4,5-TCP
25 United States, P M 437 0 1951-1987 1.6 128 253b 2,4-D; 2,4,5-1; 2,4,5-TCP
26 United States, P M 96 0 1968-1987 0.0 11 0 2,4,5-T; 2,4,5-TCP; HCP
27 United States, P M 691 0 1961-1987 1.7 58 0 2,4-D; 2,4,5-T; 2,4,5-TCP
28 United States, P M 354 0 1957-1987 1.4 50 0 2,4-D; 2,4,5-T; 2,4,5-TCP; 2,4,5-TP
29 United States, P M 113 0 1961-1987 0.0 25 0 2,4-D; 2,4,5-T; 2,4,5-TCP
30 United States, P M 121 0 1957-1987 5.0 28 0 2,4-D; 2,4,5-T; 2,4,5-TCP
31 United States, P M 96 0 1960-1987 1.0 21 0 2,4-0; 2,4,5-T; DCP; PCP
32 United States, P M 452 0 1946-1987 4.4 121 0 2,4,5-T; 2,4,5-TCP
33 United States, P M 2089 0 1942-1987 0.3 425 0 2,4-0; 2,4,5-T; 2,4,5-TCP; DCP; PCP; 2,4,5-TP;
2,4,6-TCP; TECP
34 United States, P M 265 0 1949-1987 2.3 94 0 2,4,5-TCP
35 United States, P M 163 0 1957-1987 0.6 27 0 HCP
36 United States, P M 258 0 1953-1987 1.9 62 0 2,4-0; 2,4,5-T; 2,4,5-TIP
Abbreviations: 2,4-D, 2,4-dichlorophenoxyacetic acid; 2,4-D0, 2,4-dichlorophenoxybutyric acid; 2,4-DCP, 2,4-dichlorophenol; 2,4-DP, 2,4-dichlorophenoxypropionic acid; F,
female; HCP, hexachlorophen; IARC, International Agency for Research on Cancer; M, male; MCPA, 4-chloro-2-methylphenoxyacetic acid; MCPP, 4-chloro-2-methylphe-
noxypropionic acid; P, production; PCP, pentachlorophenol; S, sprayer; 2,4,5-T, 2,4,5-trichlorophenoxyacetic acid; 2,4,5-TCP, 2,4,5-trichlorophenol; 2,4,6-TCP, 2,4,6-
trichlorophenol; 2,3,4,6-TeCP, 2,3,4,6-tetrachlorophenol; 2,4,5-TP, 2,4,5-trichlorophenoxypropionic acid. 9Aorkers exposed to phenoxy herbicides or chlorophenols but with
unknown exposure toTCDD/HCD. bAlso from cohort 26.
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with exposure information missing from
their medical histories were excluded from
the current analysis, which therefore is
based on 21,863 workers exposed to phe-
noxyacid herbicides and chlorophenols.
The cohort includes any workers ever
employed in production or spraying ofphe-
noxyacid herbicides except those in selected
cohorts for which minimum employment
periods were specified. Detailed informa-
tion on each cohort is provided in Table 1
and in previous publications (17,19-21).
The follow-up was conducted according to
a similar methodology in the different
countries and extended from 1939 to 1992
but varied by cohort. Only 4.4% of the
entire cohort was lost to follow-up
(n =970), with less than 10% lost to fol-
low-up in 33 of the 36 cohorts. Those
workers lost to follow-up were eliminated
from the study at the time ofloss. Cohort
members accumulated a total of488 and
482 person-years offollow-up.
Individual worker exposure estimates
were reconstructed usingjob records, com-
pany exposure questionnaires, and, in
some cohorts, measurements ofTCDD
and other congeners in serum or adipose
tissue and in the workplace environment.
The plant exposure questionnaire was
completed by factory personnel in the
presence ofan industrial hygienist or the
principal investigator for each study (32).
Information was elicited on procedures and
products by time period and volume, num-
ber ofworkers, and contamination ofprod-
ucts with dioxins. An extensive industrial
hygiene review was done for U.S. cohorts
by the National Institute for Occupational
Safety and Health (NIOSH) (18).
For this analysis workers were classified
by exposure to TCDD or higher chlori-
nated dioxin(s) (HCD) into three cate-
gories: those exposed to TCDD or HCD
(TCDD/HCD) (n = 13,831); those not
exposed to TCDD/HCD (n =7553); and
those having unknown amounts of expo-
sure to TCDD/HCD (n = 479). The
grouping ofTCDD with other HCD was
done because exposures often occurred
concomitantly and the compounds have
similar mechanisms of action and rela-
tively similar toxicity. Two criteria had to
be fulfilled for workers to classify as
exposed to TCDD/HCD. First, workers
must have been employed during the
period of production, formulation, or
spraying of2,4,5-trichlorophenoxyacetic
acid (2,4,5-T), 2,4,5-trichlorophenoxy
propionic acid, 2,4,5-trichlorophenol,
hexachlorophene, pentachlorophenol, or
2,3,4,6-tetrachlorophenol, because
TCDD/HCD contamination was highest
in these chemicals. Second, workers must
have been employed in plants with docu-
mented exposure to TCDD/HCD at levels
above background based on biologic or
environmental measurements; or, in the
absence ofTCDD/HCD measurements,
plants involved in production, formula-
tion, or spraying ofmore than 10 tons/year
of those compounds listed above.
Estimation of duration of exposure took
into account the exact dates and time peri-
ods of production or spraying of each
chemical. Serum TCDD measurements
were available for 573 workers from 10
cohorts (Table 1). Sampling policy for the
selection ofthese workers varied by cohort
and was in most cases nonrandom. There
was also variation among cohorts in the
time elapsed between TCDD exposure and
blood sample collection: mean TCDD
serum levels were below 20 pg/g in the
cohorts from Sweden and Australia
(sprayers) and one German cohort (n=21),
close to 50 pg/g lipid in the Dutch cohort
(n= 9) and the New Zealand cohort
(sprayers) and higher than 100 pg/g lipid
in the cohorts ofproduction workers from
Austria, the United States, and Germany
(n=22, 23); the highest mean (402 pg/g)
was found in a group of twenty 2,4,5-T
production workers with chloracne or
other symptoms from cohort 23 (Germany).
So, the available evidence suggests that
production workers have higher serum
TCDD levels than sprayers and substan-
tially higher serum TCDD levels than in
the general population.
SMR were calculated, with 95%
confidence interval(s) (CI) based on the
Poisson distribution, using the Person-Years
program (33). Expected numbers ofdeaths
were calculated bymultiplying the appropri-
ate person-years by the country-, gender-,
age-, calendar period-, and cause-specific
national death rates using the World Health
Organization Mortality Data Bank.
Gender-specific analyses for the major
causes of death were conducted for all
workers exposed to phenoxy herbicides or
chlorophenols. However, all subsequent
findings by exposure group are presented
for males and females combined because
there was no gender effect modification
and the number ofobserved deaths among
females was small in most cases. Underlying
cause ofdeath was retrieved from the death
certificate records in each country and
coded according to the revision of the
International Classification ofDiseases
(World Health Organization, Geneva) in
effect at the time ofdeath.
Internal cohort comparisons examining
mortality from selected causes of death
according to exposure to phenoxy
herbicides and chlorophenols and to
TCDD/HCD were made using Poisson
multiple regression models. Rate ratio(s)
(RR) and 95% CI derived from the analy-
sis were adjusted for country, age (10-year
groups), gender, calendar period, and
employment status (i.e., whether workers
were employed in the companies included
in the study or had left employment). The
Generalized Linear Interative Modeling
statistical package (34) was used for the
regression analysis.
Results
A total of4159 deaths occurred during the
follow-up. Cause was known for 96.4% of
the deaths. Cause-specific mortality by
gender is presented in Table 2. The all-
cause mortality for both men and women
was comparable to that expected from
national mortality rates, illustrating the
lack of an apparent healthy worker effect
for all causes combined. Among the
smaller cohort ofwomen with only 133
observed deaths, none ofthe specific cate-
gories of cause ofdeath were significantly
different from expected. Cardiovascular
disease deaths for women were not lower
than expected, as one might suspect for an
industrial cohort, and the ischemic heart
disease SMRwas 1.07 (95% CI 0.68-1.59).
A 50% nonsignificant excess mortality was
observed for external causes, accounted for
partly by the high SMR for suicide (1.46,
95% CI 0.59-3.00).
Significant excess mortality for men was
observed for all malignant neoplasms com-
bined (SMR 1.07, 95% CI 1.01-1.13) and
for symptoms and ill-defined conditions
(SMR 1.60, 95% CI 1.27-1.98). Mortality
from accidents, poisoning, and violence
(SMR 1.09, 95% CI 0.98-1.19) was also
elevated, and there were 114 deaths from
suicides (SMR 1.02, 95% CI 0.84-1.22). A
significant deficit in mortality was observed
for all diseases of the circulatory system
because oflower than expected mortality
for ischemic heart disease and cerebrovascu-
lar disease; this suggested a moderate
healthy worker selection for circulatory
diseases among men. The only other
causes of death significantly lower than
expected were diseases of the respiratory
and digestive systems.
Detailed results of cancer mortality for
specific cancers and by exposure subgroups
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Table 2. Standardized mortality ratios for major causes of death by gender among workers in the IARC international cohort study exposed to phenoxy herbicides or chloro-
phenols, 1939to 1992.
ICD-9 Males Females
Cause ofdeath classification Obs SMR 95% Cl Obs SMR 95% Cl
All causes - 4026 0.97 0.94-1.00 133 0.98 0.82-1.17
All malignant neoplasms 140-208 1083 1.07 1.01-1.13 44 0.93 0.68-1.25
Benign neoplasms 210-239 18 1.16 0.69-1.84 oa 0 0-2.95
Diseases ofthe endocrine system and blood 240-289 64 0.79 0.61-1.01 1 0.27 0.10-1.48
Mental disorders 290-319 30 0.97 0.66-1.39 ob 0 0-3.88
Diseases ofthe nervous system 320-389 40 0.77 0.55-1.05 1 0.44 0.10-2.47
Diseases ofthe circulatory system 390-459 1738 0.91 0.87-0.95 48 1.00 0.73-1.32
Ischemic heartdisease 410-414 1179 0.92 0.87-0.98 24 1.07 0.68-1.59
Cerebrovascular disease 430-438 254 0.86 0.76-0.97 9 0.73 0.33-1.38
Otherdiseases ofthe heart 415-429 166 1.11 0.95-1.29 6 0.92 0.34-2.00
Diseases ofthe respiratory system 460-519 252 0.82 0.72-0.92 7 1.06 0.43-2.19
Diseases ofthe digestive system 520-579 139 0.80 0.67-0.95 8 1.28 0.55-2.53
Livercirrhosis 571 70 0.90 0.70-1.14 3 1.27 0.26-3.70
Diseases ofthe genitourinary system 580-629 40 0.75 0.54-1.02 2 0.81 0.10-2.94
Symptoms and ill-defined conditions 780-799 82 1.60 1.27-1.98 5 1.36 0.44-3.16
Accidents, poisoning, and violence E800-E999 429 1.09 0.98-1.19 15 1.50 0.84-2.48
Suicide E950-E959 114 1.02 0.84-1.22 7 1.46 0.59-3.00
Unknown cause - 113 - - 4
Abbreviations: ICD-9, International Classification ofDiseases, Ninth Revision (World Health Organization, Geneva); Obs, observed deaths. 81.25 expected deaths. b095
expected deaths.
Table 3. Standardized mortality ratios (1939-1992) for specific causes among workers in the IARC international cohort study exposed to phenoxy herbicides or chlorophenols
by exposure toTCDD or HCD.a
Workers exposed to Workers notexposed to
TCDD/HCD(n=13,831) TCDD/HCD(n=7553)
Cause ofdeath ICD-9classification Obs SMR 95%Cl Obs SMR 95% Cl
All causes 2728 1.00 0.97-1.04 1367 0.91 0.86-0.96
All malignant neoplasms 140-208 710 1.12 1.04-1.21 398 0.96 0.87-1.06
Benign neoplasms 210-239 11 1.03 0.51-1.84 7 1.20 0.48-2.47
Diseases of the endocrine system and blood 240-289 47 0.78 0.57-1.04 17 0.71 0.41-1.14
Mental disorders 290-319 13 0.57 0.30-0.97 17 1.97 1.15-3.16
Diseases ofthe nervous system 320-389 28 0.86 0.57-1.24 12 0.59 0.30-1.03
Diseases ofthe circulatorysystem 390-459 1170 0.94 0.88-0.99 588 0.86 0.79-0.93
Ischemic heartdisease 410-414 789 0.97 0.90-1.04 394 0.85 0.77-0.94
Cerebrovasculardisease 430-438 162 0.84 0.71-0.98 96 0.86 0.70-1.05
Otherdiseases ofthe heart 415-429 138 1.20 1.01-1.42 32 0.80 0.55-1.13
Diseases ofthe respiratory system 460-519 151 0.86 0.73-1.01 102 0.76 0.62-0.92
Diseases ofthe digestive system 520-579 96 0.73 0.59-0.89 47 1.00 0.74-1.33
Livercirrhosis 571 53 0.82 0.61-1.07 19 1.28 0.77-1.99
Diseases ofthegenitourinary system 580-629 27 0.73 0.48-1.07 15 0.81 0.46-1.34
Symptoms and ill-defined conditions 780-799 65 1.83 1.42-2.34 22 1.13 0.71-1.71
Accidents, poisoning, and violence E800-E999 322 1.10 0.98-1.22 117 1.10 0.91-1.31
Suicide E950-E959 78 1.01 0.80-1.27 42 1.09 0.79-1.48
Unknown cause 86 25
&Excluded are 479 workers exposed to phenoxy herbicides orchlorophenols and with unknownTCDD/HCD exposure.
have already been reported (20). Table 3
shows noncancer mortality for specific
causes for both genders combined, strati-
fied by exposure subgroup: those exposed
to phenoxy acids orchlorophenols contam-
inated with TCDD/HCD and those
exposed to phenoxyacids or chlorophenols
but with minimal or no exposure to
TCDD/HCD.
The SMR for circulatory diseases
were below 1 in both groups. However,
workers exposed to TCDD/HCD had
somewhat higher SMR than unexposed
workers; their SMR for other diseases of
the heart were significantly increased and
could be attributed predominantly to
acute pericarditis (36% ofobservations)
and heart failure (23%). Mortality from
respiratory diseases was below expecta-
tion in both groups (p<0.05 in the
TCDD/HCD unexposed group), whereas
mortality from digestive diseases was sig-
nificantly reduced in the TCDD/HCD-
exposed group and close to expectation
in the TCDD/HCD-unexposed group.
There was a 10% excess mortality from
external causes and the SMR for suicide
were similar in both TCDD/HCD-exposed
and -unexposed groups.
InternalComparisons
Poisson regression was done to assess risk
for selected causes by measures ofexposure
to TCDD/HCD. As shown in Table 4,
risks ofmortality for all circulatory diseases
combined and ischemic heart disease were
significantly related to indices ofexposure
to TCDD/HCD. The adjusted RR for
exposure to TCDD/HCD were 1.51(95%
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Table 4. Poisson regression analyses of mortality from selected causes among workers in the IARC international cohort study and indices of exposure to TCDD or HCD, 1939
to 1992.a
All circulatory disease Ischemic heartdisease Cerebrovasculardisease Diabetes
Variables in the model RR 95% Cl Obs RR 95% Cl Obs RR 95% Cl Obs RR 95% Cl Obs
Exposure toTCDD/HCDb
No (reference category) 1.00 - 582 1.00 391 1.00 95 1.00 - 11
Yes 1.51 1.17-1.96 1151 1.67 1.23-2.26 775 1.54 0.83-2.88 161 2.25 0.53-9.50 33
Years since firstTCDD/HCD exposurec
0-9(referencecategory) 1.00 173 1.00 113 1.00 27 1.00 3
10-19 1.09 0.88-1.34 393 1.16 0.90-1.48 273 0.96 0.56-1.64 61 2.34 0.56-9.83 14
20+ 1.07 0.85-1.35 585 1.10 0.84-1.45 389 0.73 0.39-1.36 73 1.54 0.30-7.82 16
Trendd 0.69 0.71 0.22 0.96
Duration ofTCDD/HCD exposure, yearsc
Lessthan 1 (referencecategory) 1.00 248 1.00 - 187 1.00 31 1.00 - 8
1-4 1.16 0.98-1.38 370 1.05 0.86-1.29 236 1.13 0.70-1.82 54 1.07 0.39-2.94 9
5-9 1.32 1.08-1.60 220 1.17 0.92-1.48 135 1.39 0.83-2.32 38 1.01 0.28-3.62 4
10-19 1.28 1.05-1.55 233 1.21 0.96-1.53 158 1.22 0.72-2.08 34 2.52 0.89-7.11 10
20+ 0.96 0.73-1.27 80 0.98 0.70-1.36 59 0.30 0.10-0.91 4 1.13 0.20-6.43 2
Trendd 0.19 0.29 0.51 0.18
Year offirstTCDD/HCD exposurec
Before 1955 (reference category) 1.00 - 564 1.00 373 1.00 81 1.00 16
1955-1964 1.07 0.93-1.23 380 1.13 0.95-1.33 266 1.03 0.70-1.51 49 0.97 0.41-2.30 10
1965+ 1.07 0.87-1.30 207 1.03 0.81-1.32 136 1.18 0.68-2.07 31 1.76 0.58-5.31 7
Trendd 0.40 0.47 0.61 0.42
'The analysis was limited to workers with known durations of exposure and known employment status. Internal comparisons were made using Poisson regression analysis.
bRR values are adjusted for age, gender, country, calendar period, employment status, and years since first exposure and duration of exposure to phenoxy herbicides or
chlorophenols. The group exposed toTCDD/HCD is compared tothe group exposed to phenoxy herbicides orchlorophenols not contaminated with TCDD/HCD. ORR values are
adjusted for age, gender, country, calendar period, employment status, and years since first exposure and duration of exposure to phenoxy herbicides or chlorophenols.
Analysis is limited toworkers classified asexposed toTCDD/HCD. dpvalue oftestfor lineartrend.
CI 1.17-1.96) for all circulatory diseases or chlorophenols (Table 5); suicide risk was
and 1.67 (95% CI 1.23-2.26) for ischemic slightly lower in the longest latency category
heart disease. Risks did not differ across and slightly higher for latency 10 to 19
latency categories or by year of first expo- years, duration ofphenoxy herbicide and
sure but increased slightly by duration of chlorophenol exposure less than 1 year, and
exposure except for those with 20 or more year of first exposure after 1964. Other
years of exposure. Exposed workers had a causes of death, namely diseases of the
50% excess ofcerebrovascular diseases (RR endocrine system and the blood combined
1.54, 95% CI 0.83-2.88) and the findings and diseases ofthe nervous system, were not
for latency, duration, and time period of associated with indices ofexposure to either
TCDD/HCD exposure were unremark- phenoxy herbicides and chlorophenols or
able. There was an approximately 2-fold TCDD/HCD.
risk for mortality from diabetes, but the CI
was wide. The point estimate of the risk Discussion
was higher for 10 to 19 years latency, 10 to The major focus of epidemiologic studies
19 years duration of exposure, and expo- assessing the long-term consequences of
sure after 1966. Further analyses were con- exposure to TCDD has necessarily been
ducted for the inactive stratum of risks for malignant neoplasms given the
employment status separately, but most potent carcinogenicityofthis compound in
findings did not change, although the asso- experimental systems. Recent evidence
ciation between exposure to TCDD/HCD concerning mechanisms ofaction, TCDD's
and ischemic heart disease was slightly influence on biochemical and endocrine
attenuated (RR for any exposure 1.52, pathways, and morbidity effects in cross-
95% CI 1.07-2.15). sectional studies has highlighted the impor-
The risk of suicide did not differ by tance for also evaluating the noncancer
exposure group (RR in the internal compar- consequences from TCDD exposure. This
ison: 0.98, 95% CI 0.41-2.36), suggesting international cohort ofphenoxyacid herbi-
that suicide was not exclusively related to cide- and chlorophenol-exposed workers
exposure to TCDD/HCD. Therefore, an from 36 cohorts in 12 countries represents
analysis ofsuicide was conducted for the the largest study group of its kind ever
entire cohort exposed to phenoxy herbicides assembled, and allowed classification of
Table 5. Poisson regression analysis of mortality from
suicide among workers in the IARC international cohort
study exposed to phenoxyacid herbicides or chlorophe-
nols, 1939 to 1992.a
Variables in the model RR 95% Cl Obs
Years since first
exposureto herbicides
0-9(RC) 1.00 - 51
10-19 1.10 0.69-1.74 44
20 or more 0.75 0.38-1.45 24
Years of exposure
to herbicides
Lessthan 1 (RC) 1.00 58
1-4 0.81 0.53-1.25 36
5-9 0.85 0.45-1.59 14
10-19 0.92 0.45-1.90 11
20or more - 0
Year offirst exposure
to herbicides
Before 1955(RC) 1.00 - 34
1955-1964 1.52 0.90-2.56 36
1965 or after 2.30 1.24-4.27 49
RC, reference category. 'The analysis was limited to
those workers with known durations of exposure and
employment status. RR values areadjusted forage, gen-
der, country, calendarperiod, and employment status.
subgroups with and without substantial
exposure to TCDD/HCD. Mortality from
all malignant neoplasms combined was
increased for all male workers and espe-
ciallyforworkers exposed to TCDD/HCD.
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This association and cancer site-specific
analyses are presented and evaluated in
Kogevinas et al. (20).
SMR analyses suggested a moderate
healthy worker effect for all circulatory and
ischemic heart diseases for workers both
exposed and unexposed to TCDD/HCD.
Therefore there was no absolute excess in
ischemic heart disease when exposed work-
ers were compared to the general popula-
tion. However, for those exposed to
TCDD/HCD, SMR were higher 10 years
after exposure and for exposures after 1955.
For those not exposed to TCDD/HCD, the
SMR for ischemic heart disease, even after
20 years since first exposure, was 0.82
(95% CI 0.72-0.93). An association of
increased risk for ischemic heart disease
with TCDD/HCD exposure was found
through internal analysis, where confound-
ing by age, employment status, and other
time-related variables could be controlled.
Similarly, diabetes appeared to be indepen-
dently related to TCDD/HCD when
assessed by Poisson regression (Table 4).
The difference in the results between the
internal analysis (RR 1.51) and the analysis
based on external references (ratio ofthe
SMR 0.94/0.86= 1.09, Table 3) is because
ofincomparability of SMR rather than to
the confounding effect ofvariables con-
trolled for in the internal analysis; a
Poisson regression model including only
age, country, gender, and calendar period
resulted in a RR of 1.46. Higher suicide
rates than expected for a working popula-
tion were observed for all workers exposed
to any phenoxyacid herbicide or
chlorophenol. Suicide mortality is usually
lower among workers compared to the
general population, which includes the
unemployed and mentally ill (35,36).
Suicide risk was highest with latency of 10
to 19 years and short duration ofemploy-
ment. No increase was found for other
causes ofdeath.
This retrospective cohort mortality
study was hampered by the reliance on
mortality and the crudeness and inaccura-
cies ofdeath certificate diagnoses. Diseases
of interest such as endocrine and neuro-
logic outcomes likelywere underdiagnosed.
This likely affected precision, not validity
ofrisk estimates. Also, possible confound-
ing effects from important risk factors for
ischemic heart disease such as cigarette
smoking, high fat diet, blood pressure,
obesity, physical inactivity, and serum
lipids cannot be ruled out. However, excess
risk from nonmalignant respiratory disease
was not observed and the internal analysis
may have, at least in part, controlled for
confounding from known risk factors.
There is sufficient information in both
the experimental and epidemiologic litera-
ture in support ofthe biologic plausibility
of the association found between TCDD
exposure and ischemic heart disease and
diabetes. In animal studies, reported effects
include disturbances in lipid metabolism
(1,2,37), functional cardiovascular distur-
bances (38-40), and morphologic changes
in peripheral vessels (41,42). Cross-sec-
tional epidemiologic studies of highly
exposed selected populations, although
methodologically limited, suggest that
TCDD exposure might be associated with
increased prevalence ofischemic heart dis-
ease (16,23,27,30), hypertension (16,27),
diabetes (43,44), and abnormal serum
lipids (16,27,45,46). An increase in dia-
betes mortality has been shown among
women in Seveso (47). Recent evidence
from the study ofU.S. Air Force personnel
shows an inverse trend between serum
dioxin level and high density lipoprotein
and a positive trend with cholesterol (48).
Diabetes among the U.S. Air Force
personnel cohort was recently studied by
Henriksen et al. (49). Dioxin exposure
increased risk of glucose abnormalities,
diabetes prevalence and the use of oral
medications to control diabetes, and
decreased time-to-onset ofdiabetes. Our
findings ofhigher risk ofdiabetes among
TCDD/HCD-exposed workers, especially
with 10 or more years of latency and
duration of exposure, are confirmatory.
However, our results are limited by the
death certificate diagnoses and small
number ofobservations.
Recent evidence suggests that inflam-
mation may be more important in the
pathogenesis of atherothrombosis than
originally thought (50). C-reactive pro-
tein, a marker for systemic inflammation
that predicts risk for a first myocardial
infarction (50), may be a surrogate for
interleukin-6, a cellular cytokine (51).
TCDD/HCD elicits an inflammatory
response. TCDD/HCD apparently alters
gene expression in human cells ofcytokine
interleukin-1I and plasminogen activator
inhibitor-2, both ofwhich are involved in
the physiologic and pathologic process of
inflammation (52).
Most of the early mortality studies
of populations exposed to TCDD or
TCDD/HCD, induding analyses ofsubco-
horts in the present study (18,19,21,53), did
not consistently assess ischemic heart disease
mortality and most did not undertake
specific exposure assessments for TCDD.
For example, in the NIOSH cohort study
(18), the SMR for diseases ofthe heart,
including ischemic heart disease, was 0.96
(95% CI 0.87-1.06) based on 393 observed
deaths. No detailed exposure-related analysis
for ischemic heart disease was provided.
Previous studies ofcohorts included in the
NIOSH study (54-56) did not report ele-
vated SMR. The more recent update by
Collins et al. (25) of the Nitro, West
Virginia, cohort reported only an SMR for
all circulatory disease (SMR 0.90, 95% CI
0.8-1.0). Ott et al. (56) reported cause-spe-
cific mortality for the Dow Chemical
Company (Midland, MI) cohort ofphenol
production workers overall and for both
TCDD and heptooctachlorinated dioxin
indices ofexposure. Forthe entirecohortfol-
lowed to 1982, the SMR for diabetes was
0.73 (95% CI 0.20-1.86) and for diseases of
the circulatory system it was 0.93 (95% CI
0.79-1.08) based on 157 deaths. For dis-
eases ofthecirculatorysystem, the trend tests
for SMR across intensity score categories of
TCDD were not significant. Internal cohort
analyses were not conducted. Bond et al.
(57) updated the cohort to 1984 to study
cause-specific mortality among thesubgroup
with chloracne. The SMRfor arteriosclerotic
heart disease was 0.95 (95% CI 0.53-1.56)
forworkerswith chloracne.
In another small cohort (n=243)
exposed in an industrial accident (53), cir-
culatory system mortality was not elevated
in the highest exposed subgroup (SMR
0.91, 95% CI 0.51-1.50) but was higher
among all cohort members with chloracne
(SMR 1.21, 95% CI 0.83-1.70). Ott and
Zober (24) updated the follow-up to 1992
and assessed SMR by estimated TCDD
dose groups. No evidence of an effect of
TCDD on deaths from all diseases of the
circulatory system (n = 37) or ischemic
heart disease (n= 16) was observed.
In an early report ofthis study limited
to a smaller number of cohorts (19), we
reported only the SMRs for all diseases of
the circulatory system combined. The
SMR for those exposed to chlorophenoxy
herbicides or chlorophenols was 0.90 (95%
CI 0.84-0.97). Reports of individual
cohorts included in this early study indude
four British plants studied by Coggon et al.
(31), a cohort ofCanadian sprayers (58),
and two Dutch plants (59). The SMR for
circulatory disease among British workers
with greater than background exposure to
herbicides or chlorophenols was 1.17, but
the excess appeared to be confined to plant
A workers (SMR 1.66) (31). Green (58)
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reported an SMR of 0.92 (95% CI
0.61-1.34) for all diseases ofthe circula-
tory system in a Canadian cohort ofpub-
lic utility forestry workers who applied
herbicides. Among the Dutch workers the
RR for circulatory disease mortality was
1.70 (95% CI 0.90-3.20) comparing
workers exposed to phenoxy herbicides or
chlorophenols and nonexposed subjects.
None of these studies assessed TCDD
exposure. However, a cohort of German
chemical workers included in the
present study who manufactured 2,4,5-
trichlorophenol and 2,4,5-T as well as
chemicals contaminated with dioxins was
compared to gas workers using a quantita-
tive measure ofdioxin exposure (21). All
cardiovascular disease and ischemic heart
disease showed a dose-dependent relation-
ship with TCDD and all dioxins/furans
combined. The relative risk for ischemic
heart disease in the highest TCDD/HCD
exposure group was 2.48 (95% CI
1.32-4.66).
The most recent update ofthe U.S. Air
Force personnel study (60) shows an
increase ofischemic heart disease among
nonflying enlisted men (SMR 1.49, 95%
CI 0.98-2.19, n=24), although not in
other subgroups using a comparison group
ofnonexposed servicemen. Thelargest sub-
group and also the highest dioxin exposure
based on serum levels is nonflying enlisted
men. The most recent 15-year follow-up of
the Seveso population showed a significant
increase in circulatory disease among males
(RR 1.6, 95% CI 1.1-2.5, n=21) and
ischemic heart disease among males (RR
1.5, 95% CI 0.3-4.5, n=9) in the highest
exposure zone (zone A), although females
showed no elevation in zoneA (61).
The higher-than-expected SMRs for
suicide for an employed population (35,36)
in this cohort ofworkers exposed to phe-
noxyacid herbicides and chlorophenols con-
firms the previous observations ofGreen
(58,62) and Becher et al. (22). Green (62)
postulated that the neurologic toxicity of
phenoxyacid herbicide exposure might have
psychiatric manifestations such as suicide.
The documented neurologic toxicityofphe-
noxyacid herbicides (63) and their expo-
sure-associated personality changes,
neurologic disturbances (64), and depres-
sion (65) have been hypothesized as consid-
erations in the evaluation ofsuicide risk
among exposed cohorts (58). The higher
rates ofsuicide among workers with short
durations ofexposure in the present study
suggest that perhaps those susceptible to
psychiatric manifestations ofexposure are at
risk during the first few years ofexposure.
Alternatively, the excess may have occurred
by chance or as a consequence ofnonoccu-
pational confounding factors. Further study
ofthe biologic and clinical basis for suicide
among phenoxyacid herbicide-exposed
workers iswarranted.
The results of this cohort study
reinforce the hypothesis that exposure to
TCDD/HCD increases the risk for
ischemic heart disease and perhaps dia-
betes. It seems somewhat paradoxic that
investigations of a few subcohorts with
previous TCDD/HCD exposure esti-
mates, which comprise this expanded
international cohort, did not reveal an
association with circulatory disease.
However, the cohort reported by Ott et
al. (56) was followed only to 1982 and
the Badische Anlin- und Sodafabrik
(Ludwigshafen, Germany) cohort had a
small number of observed events (24).
The present investigation had the advan-
tages of a systematic and consistent
TCDD/HCD exposure assessment that
was validated with biologic and environ-
mental sampling (20), substantial sample
size, and extended latency periods.
Nonetheless, the current study had
important limitations, including reliance
on mortality measures, lack of specific
quantitative measures of exposure to
TCDD/HCD for each worker, and the
inability to authoritatively rule out con-
founding from other occupational and
lifestyle exposures. Refined risk estimates
based on more explicit exposure estimates
would be informative and important
given the ubiquitous environmental cont-
amination offood, soil, and water with
TCDD/HCD.
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